Global specialty ingredients Proposed business U.S. rules verified October 2026

International ingredients reach U.S. manufacturers on documented evidence, and EUTECNIQ proposes to build that evidence with qualified suppliers

A proposed business line: find and qualify international botanical ingredients, close their U.S. identity, safety and regulatory gaps, improve them where data justify it, and supply them to U.S. manufacturers.

Status. EUTECNIQ Sciences is a company in formation. It has no supplier, distribution or customer agreements, no laboratory and no imported products. Everything below describes how the business would work.

Academy fundamentals: Course 5, Soil and cultivation · Course 6, Certificate-of-analysis science

30CFR rule sets mapped for an importer of bulk botanical ingredients, across FDA, CBP, USDA and EPA rules

2 · 4 · 8 hminimum lead time for confirmed FDA prior notice by road, rail or air, and water (21 CFR 1.279)

10working days after entry to file the CBP entry summary (19 CFR 142.12)

Oct 1–Dec 31of every even year: FDA food facility registrations must be renewed (21 CFR 1.230(b))

Who this is for

Two sides of the same transaction would be served by one documented pathway

Choose a party to follow its path from the rules to the documents it would receiveProposed service flow

Rules link to eCFR. Stages and documents are EUTECNIQ proposals; EUTECNIQ has no supplier, distribution or customer agreements and no laboratory.

Text version: parties, rules, stages and documents

Parties

Overseas ingredient manufacturers Need U.S.-ready evidence and a route to buyers (see for suppliers).
U.S. manufacturers Need an ingredient they can qualify under their own legal duties (see for buyers).
Brands Need a documented ingredient and application support in their own product.

Rules that apply

21 CFR 1, Subpart H Food facility registration, including foreign facilities.
21 CFR 1, Subpart I Prior notice of imported food.
21 CFR 1, Subpart L Foreign supplier verification; § 1.511 for supplements.
21 CFR 111 Identity test and specifications at the supplement maker.
21 CFR 117 Food CGMP and supply-chain program for ingredient makers.
21 CFR 190.6 New dietary ingredient notification where needed.

Stages (proposed)

Qualified international supplier Audit, records, specification agreed.
Analytical and safety development Identity, contaminants, stability.
Regulatory strategy Pathway for each intended use.
Formulation improvement Only where data justify it.
U.S. distribution Entry, prior notice, receipt testing.
Commercial supply agreement Change control and lot documents.

What each party would receive

EUTECNIQ would own the evidence between supplier and buyer; partners would test, audit, ship and adviseProposed roles

Roles are EUTECNIQ's proposal. FDA does not approve dietary ingredients; a notification is not an approval (21 U.S.C. 350b; 21 CFR 190.6).

Text version of the roles

EUTECNIQ would Proposed

Select and qualify suppliers, and set the specification
Plan and review identity, contaminant and stability testing
Decide the U.S. regulatory pathway for each intended use
Own the U.S. documentation and technical support

Qualified partners would External partner

Run laboratory testing until EUTECNIQ has its own laboratory
Conduct third-party audits where needed
Provide customs brokerage, freight and warehousing
Give legal and regulatory counsel opinions

EUTECNIQ does not claim Limits

Any signed supplier, distribution or exclusivity agreement
That any ingredient is approved by FDA; FDA does not approve dietary ingredients
That a supplier's certificates establish U.S. marketability
Any price, margin or volume for this business

EUTECNIQ proposes to sit between an overseas manufacturer and a U.S. manufacturer and own the evidence that connects them. An overseas manufacturer needs U.S.-ready evidence and a route to buyers. A U.S. manufacturer needs an ingredient it can qualify under its own legal duties.

Suppliers

For international ingredient manufacturers

Inputs, documents and decisions.

Supplier pathway →

Buyers

For U.S. manufacturers and brands

Documents, testing and change control.

Buyer pathway →

Partners

Co-development and licensing

Engagement models, IP and royalties.

Engagement models →

Data

Global botanical trade data

Where medicinal-plant material moves.

Trade data →

Proposed pathway

Six stages would take an ingredient from a qualified foreign supplier to a U.S. supply agreement, each ending at a written gate

Six stages, six written gates: what each stage documents and what must be true to continueProposed gate criteria

Stage structure and criteria: EUTECNIQ proposal, to be approved before use. FDA import alerts and refusals are reviewed at stage 1; FSVP and prior notice roles are planned at stage 3 (21 CFR Part 1, Subparts I and L).

Text version: activities, documents, gate and owners for each stage

Stage 1

Qualified international supplier

Activities: Source search; supplier questionnaire; mutual NDA; desk review of process, specifications, certificates of analysis and regulatory history, including FDA import alerts and refusals; on-site audit; development samples; risk ranking for identity, contamination, origin and continuity.
Documents: Questionnaire, audit report and corrective actions, supplier risk assessment, draft quality agreement, approved-supplier record.
Decision gate: Approve the supplier for development work only if species, plant part and process are disclosed, no critical audit finding is open, and the supplier accepts change notification and audit rights.

EUTECNIQ, proposed Third-party auditor where needed

Stage 2

Analytical and safety development

Activities: Identity confirmation on several lots with orthogonal methods; chemical fingerprint against authenticated reference material; marker assay; contaminant testing chosen by risk; stability screening; safety literature, exposure and interaction review.
Documents: Identity method and results, comparison of independent results with the supplier's certificates, draft specification with a reason for each limit, safety evidence summary with gaps.
Decision gate: Proceed if the identity method works on real lots, independent results confirm the supplier's certificates, contaminants meet justified limits, and no hazard is known at the intended exposure.

Qualified external laboratories EUTECNIQ plan and data review

Stage 3

Regulatory strategy

Activities: Fix the intended U.S. use and claims; decide the legal category; for supplement use, assess new-dietary-ingredient status; for food use, assess GRAS status for the use level; plan import roles under FSVP and prior notice; check other target markets separately.
Documents: Regulatory market-access file, NDI status memo, claims plan, FSVP role plan, list of evidence gaps with cost and time.
Decision gate: Proceed if a lawful pathway exists for the intended use and the evidence it needs can be produced at an acceptable cost. Counsel reviews the conclusion where the question is legal.

EUTECNIQ regulatory science, proposed Regulatory counsel

Stage 4

Formulation improvement

Activities: Application testing in target formats; dispersibility, matrix stability and processing work; delivery forms such as emulsions or spray-dried powders only when a measured limitation justifies them.
Documents: Application development report, stability protocol and data, delivery dossier where evidence exists.
Decision gate: Proceed if the improved form meets its specification and stability targets. Any change in process or composition returns to stage 3, because it can change regulatory status.

EUTECNIQ formulation science, proposed Contract development partners at first

Stage 5

U.S. distribution

Activities: Agree who is the importer; foreign facility registration check; prior notice and customs entry through a licensed broker; controlled warehousing; receipt testing and release; samples and technical sales; customer qualification support.
Documents: FSVP records, entry documents, lot certificates of analysis, technical and safety data sheets, allergen and composition statements, customer qualification packet.
Decision gate: Continue if first commercial lots clear entry, meet specification on receipt and pass customer qualification, and the landed cost stays within the agreed range.

EUTECNIQ, proposed Customs broker, freight and warehouse providers

Stage 6

Commercial supply agreement

Activities: Negotiate forecasts, pricing mechanism, minimum order and lead time, specification exhibit, change notification, audit rights, recall and indemnity terms, territory and exclusivity; run periodic supplier re-qualification and annual review.
Documents: Supply agreement, quality agreement, specification exhibit, change-control procedure, annual supplier and product review.
Decision gate: Renew, expand or exit on measured performance: lots accepted, deviations, complaints, on-time delivery and margin against plan.

EUTECNIQ, proposed Commercial counsel

Explanation, details and sources

A stage starts only when the previous gate is passed. A gate can stop the work, send it back, or let it continue. The criteria below are EUTECNIQ's proposal and would be approved before use.

Global ingredient network

Source type, main risk, intended use and commercial model combine into different routes to the U.S. market

Representative routes from source to U.S. buyerIllustrative network

1Source

2Characterization focus

3U.S. regulatory development

4Commercial route

Six representative routes

Every route needs all four characterization activities; the highlighted one marks where the archetype's main risk sits. Choose a route or a stage for detail. The same content is listed in the text version below.

Text version: every stage and route in the network

Representative routes

Route	Path	Why this path
Cultivated root for capsules	Cultivated raw material → botanical identity → dietary supplement use → exclusive U.S. distribution	For whole or powdered plant material, substitution with related species is the main risk. A long-marketed ingredient may not need a notification, but that conclusion must be documented. Exclusive distribution suits a supplier with no U.S. presence.
Extract from a changed process	Extract manufacturer → chemical fingerprint and markers → dietary supplement use → co-development	A new solvent or concentration step can change composition enough to raise the question whether the extract is a new dietary ingredient. Co-development shares the cost of the identity and safety evidence and assigns the rights to it.
Wild-collected skin-care botanical	Wild-collected raw material → contaminants and adulterants → cosmetic use → manufacturer's representative	Legal origin and contamination dominate the risk. Cosmetic use needs safety substantiation, not premarket approval. A representative model needs little capital while volumes are uncertain.
Encapsulated extract for beverages	Specialty ingredient processor → stability → conventional food use → master distributor	Stability in the drink and the GRAS status of every component at the use level decide feasibility. A master distributor can reach many beverage formulators through channel partners.
Branded standardized extract	Extract manufacturer → chemical fingerprint and markers → dietary supplement use → private-label specialty ingredient	The brand owner carries the specification and documentation responsibility. Fingerprint limits keep lots from different harvests consistent under one name.
Botanical drug candidate	Extract manufacturer → contaminants and adulterants → drug development, partner-led → co-development	A disease claim makes the product a drug, which needs an investigational new drug application and drug manufacturing rules. EUTECNIQ's proposed role would be characterization and partnering, not drug manufacture.

1. Source

Cultivated raw material

What happens: Plants are grown under documented cultivation and harvest practices, then dried and cut or powdered.
Documents: Species and plant-part declaration, farm or region records, harvest and drying records, lot genealogy.
Decision gate: Species and plant part can be verified on each received lot.
Who: Supplier records; EUTECNIQ review (proposed).
Main risks: Substitution with related species, pesticide residues, marker content that varies between harvests.

Wild-collected raw material

What happens: Material is collected from wild populations, often through several intermediaries.
Documents: Collection permits, chain of custody, sustainability evidence; for a species listed in CITES Appendix II, an export permit from the exporting country's management authority.
Decision gate: Legal origin is documented and identity is verified on each lot.
Who: Supplier and collectors; EUTECNIQ review (proposed).
Main risks: Misidentification, adulteration, unstable supply, legal-origin and sustainability risk.

Extract manufacturer

What happens: Raw material is extracted, concentrated, sometimes standardized to marker compounds, and dried.
Documents: Process flow, solvents, ratio of raw material to extract, carriers and excipients, residual-solvent data, certificates of analysis.
Decision gate: Process and inputs are disclosed under NDA, and independent results match the supplier's certificates.
Who: Supplier; independent testing by external laboratories (proposed).
Main risks: Undeclared spiking or dilution with carriers; a process change that alters composition and regulatory status.

Specialty ingredient processor

What happens: An extract is turned into a formulated ingredient, such as a spray-dried, encapsulated or emulsified form.
Documents: Full composition, excipient specifications, stability data.
Decision gate: Every component is identified and permitted for the intended use, and stability supports the proposed retest date.
Who: Supplier; EUTECNIQ review (proposed).
Main risks: Excipients whose status differs by use, performance claims without data, physical instability.

2. Characterization focus

Botanical identity

What happens: Species, plant part and preparation are confirmed. Raw material: macroscopic and microscopic examination plus a chemical method. Extracts: chemical methods against authenticated reference material.
Documents: Identity method, results, reference-material records.
Decision gate: The method distinguishes the likely substitutes and works on real lots.
Who: Qualified external laboratories at first; EUTECNIQ sets the plan and reviews data (proposed).
Main risks: A method that confirms a marker compound but misses a substitute plant.

Chemical fingerprint and markers

What happens: A chromatographic profile, for example by HPTLC or HPLC, is compared with reference lots, and marker compounds are quantified.
Documents: Fingerprint acceptance criteria, marker assay, lot-to-lot comparison.
Decision gate: The profile is reproducible across several lots and its acceptance limits are justified.
Who: Qualified external laboratories at first; EUTECNIQ review (proposed).
Main risks: Marker content held constant while the rest of the composition drifts.

Contaminants and adulterants

What happens: Tests are chosen by risk for the plant, origin and process: toxic elements such as lead, cadmium, arsenic and mercury; pesticide residues; microbiological quality; mycotoxins; residual solvents; undeclared substitutes or additives.
Documents: Contamination risk assessment, results on several lots, proposed limits with their basis.
Decision gate: Results fall within limits justified for the intended daily intake.
Who: Qualified external laboratories at first; EUTECNIQ review (proposed).
Main risks: Too few lots tested; limits set without reference to intake.

Stability

What happens: Stress and real-time studies on representative lots in the intended packaging support a retest date.
Documents: Stability protocol and data.
Decision gate: Data support the proposed retest date under shipping and storage conditions. Ingredient stability testing does not establish a validated shelf life for a finished product.
Who: Qualified external laboratories at first; EUTECNIQ review (proposed).
Main risks: Degradation during hot or humid transit; interaction with the container.

3. U.S. regulatory development

Dietary supplement use

What happens: Two questions are answered and documented. Was the ingredient marketed in the United States before October 15, 1994? If not, it is a new dietary ingredient, and a notification is required unless the strict food-supply exception applies. A required notification is filed at least 75 days before marketing (21 CFR 190.6).
Documents: NDI status memo, safety dossier, draft notification when needed.
Decision gate: A lawful pathway exists and its evidence can be produced. FDA does not approve notifications.
Who: EUTECNIQ regulatory science (proposed); counsel where needed. The customer manufactures under 21 CFR Part 111.
Main risks: An undocumented NDI conclusion; a process change that reopens it.

Conventional food use

What happens: Each ingredient must be generally recognized as safe (GRAS) under its intended conditions of use (21 CFR 170.30) or be an approved food additive (21 U.S.C. 348). GRAS notification is voluntary today; a rule proposed on August 11, 2026 would make it mandatory.
Documents: Intended-use and exposure assessment, GRAS conclusion or notice.
Decision gate: A GRAS basis exists for the specific use and level.
Who: EUTECNIQ regulatory science (proposed); expert panel and counsel.
Main risks: A conclusion for one use level relied on for another.

Cosmetic use

What happens: No premarket approval. The responsible person must hold adequate substantiation of safety; facilities register and products are listed under MoCRA. A claim to affect the structure or function of the body makes the product a drug.
Documents: Ingredient characterization and safety file supporting the product's safety assessment.
Decision gate: Claims stay cosmetic and safety substantiation can be supported.
Who: EUTECNIQ (proposed) supplies the ingredient file; the brand is the responsible person.
Main risks: Marketing language that creates a drug intended use.

Drug development, partner-led

What happens: A product intended to diagnose, cure, mitigate, treat or prevent disease is a drug. Development runs under an investigational new drug application and then a new drug application, with drug CGMP under 21 CFR Parts 210 and 211.
Documents: Characterization and chemistry, manufacturing and controls packages prepared with pharmaceutical partners.
Decision gate: A pharmaceutical partner commits to the program.
Who: Pharmaceutical partners lead. EUTECNIQ would not make drug products under Part 111.
Main risks: Clinical failure; drug manufacturing requirements far beyond supplement practice.

4. Commercial route

Exclusive U.S. distribution

What happens: EUTECNIQ would buy, import and resell the ingredient with exclusive U.S. rights for defined products and fields.
Documents: Distribution agreement, quality agreement, FSVP records as importer.
Decision gate: Demand evidence supports the minimum purchase commitment.
Who: EUTECNIQ (proposed).
Main risks: Inventory and working capital; minimum commitments; one supplier.

Manufacturer's representative

What happens: EUTECNIQ would sell on the supplier's behalf for a commission and would not take title to goods.
Documents: Representation agreement, commission schedule, technical sales materials.
Decision gate: The supplier's documentation already meets U.S. buyers' needs.
Who: EUTECNIQ sells; the supplier or customer imports.
Main risks: No control over quality or import compliance; customer relationships lost at termination.

Master distributor

What happens: EUTECNIQ would hold U.S. rights and supply sub-distributors and channel partners.
Documents: Master and sub-distribution agreements, channel traceability records.
Decision gate: Channel partners accept documentation and traceability duties.
Who: EUTECNIQ (proposed) with channel partners.
Main risks: Channel conflict; recall coordination across several firms.

Co-development

What happens: EUTECNIQ and the supplier, or a pharmaceutical partner, would develop an improved ingredient together under agreed cost, data and IP terms.
Documents: Co-development agreement, development plan with gates, IP and data schedule.
Decision gate: Both parties approve each stage on its data.
Who: Shared, by contract.
Main risks: Disputed ownership of new IP and data; technical failure.

Private-label specialty ingredient

What happens: A contract manufacturer abroad would make the ingredient to EUTECNIQ's specification for sale under an EUTECNIQ ingredient name.
Documents: Manufacturing and quality agreements, specification owned by EUTECNIQ, trademark clearance.
Decision gate: The specification and documentation can carry EUTECNIQ's name.
Who: EUTECNIQ owns the specification; the manufacturer produces.
Main risks: EUTECNIQ carries responsibility for every marketing statement and for supply continuity.

Illustrative archetypes for teaching. Edges show the six example routes only; real programs often combine several sources, uses and models. No supplier, ingredient, agreement or volume is implied.21 CFR 190.6; 21 U.S.C. 350b(a), (d) (NDI definition and notification); 21 CFR 170.30; 21 U.S.C. 348; 91 FR 51834 (proposed, August 11, 2026); 21 U.S.C. 364a–364d (MoCRA); 21 U.S.C. 321(g); 21 CFR Parts 210, 211; CITES Appendix II permit rules (cites.org).

Explanation, details and sources

Select a representative route, or any stage in a column, to see what would happen there, the documents it produces, its gate and who would do the work. The routes are teaching archetypes. They do not describe any supplier, ingredient or agreement.

Commercial models

Five proposed models differ in who holds title, who imports and who carries the inventory risk

The model would be chosen supplier by supplier, from the evidence each one already has and the demand EUTECNIQ can show.

Follow the goods: where title, FSVP duties and inventory risk sit in each modelProposed models

The FSVP importer is the U.S. owner or consignee of the food at entry; if there is none, the foreign owner's designated U.S. agent with signed consent (21 CFR 1.500, 1.509). The commercial model therefore decides who carries FSVP duties. None of these agreements exists today.

Text version: each model's roles, revenue and risks

Exclusive U.S. distribution

EUTECNIQ would buy from the supplier, take title, import and resell to U.S. manufacturers, with exclusive rights for defined products, fields and territory, usually against minimum purchase commitments.

EUTECNIQ: Importer and FSVP duties, inventory, credit, U.S. documentation, technical sales, complaints
Supplier: Manufacture to specification, quality agreement, change notification, capacity
Revenue: Resale margin
Main risks: Working capital tied up in stock; minimums missed; a supplier quality failure or import detention

Manufacturer's representative

EUTECNIQ would act as the supplier's sales agent in the United States. The supplier invoices and ships; EUTECNIQ never owns the goods.

EUTECNIQ: Lead generation, technical selling, sample coordination, customer feedback
Supplier: Supply, invoicing, documentation and import arrangements with the customer
Revenue: Commission on sales in the territory
Main risks: No control of quality or compliance; commission disputes; accounts lost when the agreement ends

Master distributor

EUTECNIQ would hold the U.S. rights and appoint and supply sub-distributors and channel partners, setting channel terms and training.

EUTECNIQ: Import, inventory, channel management, traceability through every sub-distributor
Supplier: Supply and documentation as for exclusive distribution
Revenue: Wholesale margin on sales to channel partners
Main risks: Channel conflict; inconsistent documentation downstream; recalls across several firms

Co-development

EUTECNIQ and the supplier would jointly develop a differentiated ingredient, such as a better-characterized grade, a delivery form or a stronger safety dossier, and then commercialize it under a supply or license agreement.

EUTECNIQ: Development plan, analytical and regulatory science, application work
Supplier: Process access, pilot material, manufacturing changes, cost share
Revenue: Development fees, milestones, royalties or a share of supply margin
Main risks: Disputes over new IP and data; technical failure; a modification that changes regulatory status

Private-label specialty ingredient

A contract manufacturer abroad would make an ingredient to EUTECNIQ's specification, sold under an EUTECNIQ ingredient name.

EUTECNIQ: Specification, name and trademark, documentation, substantiation of any ingredient marketing statement, complaints
Supplier: Manufacture to EUTECNIQ's specification under a quality agreement and confidentiality
Revenue: Product margin
Main risks: Full responsibility for the product's claims and continuity; dependence on one manufacturer

Who carries what under each model

Model	Title to goods	Usual FSVP importer	Inventory risk	Capital need
Exclusive U.S. distribution	EUTECNIQ	EUTECNIQ, as U.S. owner or consignee at entry	EUTECNIQ	High
Manufacturer's representative	Supplier, then customer	The U.S. customer, or the supplier's designated U.S. agent	Supplier or customer	Low
Master distributor	EUTECNIQ, then channel partners	EUTECNIQ when it imports	EUTECNIQ and channel partners	High
Co-development	Set by the supply terms	Whoever owns or receives the goods at entry	Shared, by contract	Medium
Private-label specialty ingredient	EUTECNIQ	EUTECNIQ	EUTECNIQ	High

Capital need is a qualitative management judgment.

Explanation, details and sources

Trading

Import a standardized extract and sell it on a distribution margin

Fast and cheap to start, but the documentation is the supplier's, so the ingredient competes on price and is easy to copy.

Development-led distribution

Set specifications, close safety and documentation gaps, then supply

Creates assets a competitor cannot copy quickly: data, specifications and contract rights. Its margins and adoption are unproven until real sales show them.

Related arrangements described elsewhere

Arrangement	What EUTECNIQ would do	Revenue mechanism
Non-exclusive specialty distribution	Qualify suppliers, import, warehouse and sell from a catalog	Distribution margin
Regulatory commercialization partner	Close a supplier's U.S. identity, safety or documentation gaps as a paid project (supplier pathway)	Development fees; negotiated commercial rights
Technology licensor	License formulation or process know-how (engagement models)	Upfront fees, milestones, royalties
Technical sales and applications partner	Pair ingredient supply with formulation support for customers	Product margin plus development fees

Supplier qualification

Qualification turns a supplier's statements into evidence that EUTECNIQ and its customers can rely on

Each element would be written into the supply relationship before commercial volumes move. U.S. rules set the floor; the rest is proposed practice.

Four elements are required by regulation; five more would be EUTECNIQ practice on top of themRegulation Proposed practice

eCFR, 21 CFR 111.70(b), 111.75(a), 117.405 and 111.1, up to date as of October 20, 2026.

Text version: what each element establishes, and its basis

Element	What it establishes and how	Basis
Audits	Whether the site can make the ingredient consistently: process controls, cleaning, sanitation, testing, records and complaint handling. On-site where risk is high; desk review plus samples where it is low. Findings close through corrective actions.	Proposed practice
Quality agreement	Who tests, who releases, how deviations, complaints, recalls and changes are handled, and which records the supplier keeps and shares.	Proposed practice
Technical agreement and specification	The agreed specification for identity, purity, strength, composition and contaminant limits, with test methods and the reason for each limit.	21 CFR 111.70(b) sets component specifications for supplement makers
Identity testing	Independent confirmation of species, plant part and preparation on received lots. A supplement maker must test the identity of each dietary ingredient itself; it cannot rely on the supplier's certificate for identity.	21 CFR 111.75(a)(1)
Certificate reliance	For other specifications, a supplier's certificate may be relied on only after the supplier is qualified by confirming its results; the certificate must show methods, limits and actual results, and is re-confirmed periodically.	21 CFR 111.75(a)(2)
Chemical fingerprinting	A chromatographic profile compared with authenticated reference lots, which detects substitution and composition drift that a single marker assay can miss.	Proposed practice
Contamination risk	Hazards ranked by plant, origin, cultivation or collection, and process; tests and limits chosen to match. A dietary-ingredient facility is generally under 21 CFR Part 117, which requires a risk-based supply-chain program when the receiving facility identifies a hazard that its supplier controls, unless an exemption applies.	21 CFR 117.405
Supplier change control	Advance written notice of any change to species source, region, harvest practice, solvent, process, site or carrier; EUTECNIQ assesses comparability and regulatory impact before accepting changed lots.	Proposed practice
Traceability	Lot genealogy from raw material to shipped lot, chain of custody, certificates of origin and periodic mock trace exercises.	Proposed practice

eCFR, 21 CFR 111.70, 111.75 and 117.405, up to date as of October 20, 2026. Part 111 applies to persons who manufacture, package, label or hold a dietary supplement (21 CFR 111.1); a dietary-ingredient-only operation is generally under Part 117 (FDA Small Entity Compliance Guide, 2010; 80 FR 55908, 2015).

U.S. import compliance

An imported botanical for food or supplement use must clear FDA and customs requirements before any U.S. customer can use it

Five parties act on one shipment; the U.S. customer still qualifies the lot after releaseRegulation and statute

eCFR, 21 CFR 1.225, 1.226(a), 1.227, 1.230(b), 1.277, 1.279, 1.500, 1.509, 111.75(a); 19 CFR 142.3, 142.12 (up to date as of October 20, 2026); 21 U.S.C. 381(a); FDA, Import Alerts (content current as of March 3, 2025); CITES Secretariat, How CITES works.

Prior notice must be confirmed hours before arrival, and cannot be filed more than 15 or 30 days ahead21 CFR 1.279

eCFR, 21 CFR 1.277 and 1.279, up to date as of October 20, 2026. Prior notice also covers quality-control and trade samples.

Text version of the import steps

Foreign facility registration

The overseas site registers with FDA

A foreign facility that manufactures, processes, packs or holds food for U.S. consumption must register, unless another foreign facility further processes the food beyond minor steps such as labeling. Registrations are renewed from October 1 to December 31 of each even-numbered year.

21 CFR 1.225, 1.226(a), 1.230(b)

Prior notice

FDA is told about each shipment before it arrives

Prior notice must be confirmed by FDA at least 2 hours before arrival by road, 4 hours by rail or air and 8 hours by water, and no earlier than 30 days ahead through customs systems or 15 days through FDA's interface. It covers quality-control and trade samples too.

21 CFR 1.277, 1.279

Customs entry

The entry package goes to CBP through a broker

Release needs the entry filing (CBP Form 3461 or its electronic equivalent), evidence of the right to make entry, a commercial invoice, a packing list where appropriate, and any documents other agencies require. The entry summary with estimated duties follows within 10 working days unless filed at entry.

19 CFR 142.3, 142.12

Admission

FDA can hold or refuse food that appears noncompliant

FDA refuses admission when an article appears adulterated or misbranded, made under insanitary conditions, or forbidden or restricted in sale where it was produced or exported. Products on an import alert can be detained without physical examination, and are refused unless the importer shows they are compliant.

21 U.S.C. 381(a) FDA import alerts page

Other agencies can apply as well. For a species listed in CITES Appendix II, international trade needs an export permit from the exporting country's management authority, issued only for legally obtained specimens whose export will not harm the species' survival.

FSVP makes the importer verify its foreign suppliers; § 1.511 lightens that duty when a Part 111 firm tests the materialFinal regulation

Where EUTECNIQ imports for a customer that is not a Part 111 manufacturer, or for food use, the full FSVP requirements would apply: § 1.511(c) covers finished dietary supplements only.eCFR, 21 CFR 1.500–1.514, up to date as of October 20, 2026; FSVP final rule, 80 FR 74226 (November 27, 2015).

Text version: the three § 1.511 scenarios

Scenario	Who it covers	Must comply with	Not required
§ 1.511(a)	An importer that itself must set specifications under § 111.70(b) or (d) for a dietary supplement or component it imports for further manufacturing, processing or packaging as a supplement, and complies with §§ 111.73 and 111.75	§ 1.503 (qualified individual) and § 1.509 (importer identification at entry)	§§ 1.502, 1.504–1.508 and 1.510
§ 1.511(b)	An importer whose customer is subject to and compliant with those Part 111 requirements, and obtains annual written assurance of this from the customer	§§ 1.503, 1.509 and 1.510 (records)	§§ 1.502 and 1.504–1.508
§ 1.511(c)	Other dietary supplement importers, for example of finished supplements	Approved-supplier procedures; written verification procedures; documented choice of verification activities (onsite audit, sampling and testing, record review, or other); verification before importing and periodically thereafter; §§ 1.503, 1.505(a)(1)(ii)–(iv), (a)(2), (b)–(d), and 1.508–1.510	Hazard analysis (§ 1.504) and §§ 1.505(a)(1)(i), 1.506 and 1.507

For EUTECNIQ as a bulk-ingredient importer, the practical route would usually be § 1.511(b): its customers are the Part 111 firms that test incoming material, and EUTECNIQ would collect their annual written assurance. Where EUTECNIQ imports for a customer that is not a Part 111 manufacturer, or for food use, the full FSVP requirements apply.

eCFR, 21 CFR 1.500–1.514, up to date as of October 20, 2026; FSVP final rule, 80 FR 74226 (November 27, 2015). Under § 1.511(c), verification must give adequate assurance that the supplier produces under processes that provide "the same level of public health protection as those required under part 111." Sections 1.511(a) and (c) do "not limit your obligations with respect to part 111." Final regulation

eCFR, 21 CFR Part 1 Subparts H, I and L and 19 CFR Part 142, up to date as of October 20, 2026; 21 U.S.C. 381(a) (Cornell LII); FDA, Import Alerts, content current as of March 3, 2025; CITES Secretariat, How CITES works.

Explanation, details and sources

Dietary supplements and dietary ingredients are food for FDA registration (21 CFR 1.227), so prior notice and FSVP apply. Cosmetic-use imports follow other rules. Summaries as of October 2026; not legal advice.

A foreign GMP certificate or a certificate of analysis does not by itself make an ingredient marketable in the United States

A GMP certificate describes a manufacturing system, not the ingredient's U.S. status for its intended use: NDI status, GRAS status for a food use, or a drug use created by claims. A certificate of analysis reports one lot by the supplier's own methods; the buyer still tests identity itself (21 CFR 111.75(a)).

Thirty CFR rule sets touch an importer of bulk botanical ingredients, across FDA, CBP, USDA and EPA ruleseCFR counts

Area is the number of sections in eCFR, a measure of length, not of importance; "*" marks rules that apply only in the circumstances they name, such as APHIS plant-import rules or CITES permits. Select a part to open it in eCFR.Applicability as mapped on the CFR atlas (its import walkthrough follows one container); section counts from the eCFR API, up to date as of October 21, 2026. Orientation, not legal advice.

Data table: every rule set in the treemap

CFR parts for a importer of bulk botanical ingredients: An importer of bulk botanical ingredients for supplement and food makers (eCFR section counts)
Rule set	What it covers	Agency group	eCFR sections	Level
21 CFR Part 111	Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. CGMP for anyone who makes, packages, labels or holds a dietary supplement, including identity tests of dietary ingredients.	FDA · 21 CFR	84	Applies
21 CFR Part 117	Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food. CGMP, hazard analysis and preventive controls for human food, including dietary ingredients.	FDA · 21 CFR	61	Applies
21 CFR Part 101	Food Labeling. Food labels: Supplement Facts (§ 101.36), health claims (§ 101.14) and structure/function statements (§ 101.93).	FDA · 21 CFR	50	Applies
21 CFR Part 1, Subpart R	Laboratory Accreditation for Analyses of Foods. Certain food tests, such as tests to support admission of an import, must be run by a LAAF-accredited laboratory.	FDA · 21 CFR	42	Check
21 CFR Part 1, Subpart O	Sanitary Transportation of Human and Animal Food. Shippers, loaders, carriers and receivers keep food safe during transport; § 1.900(b) lists exempt operations.	FDA · 21 CFR	18	Check
21 CFR Part 1, Subpart L	Foreign Supplier Verification Programs for Food Importers. Importers verify that foreign suppliers produce food safely; § 1.511 modifies the program for dietary supplements.	FDA · 21 CFR	15	Applies
21 CFR Part 1, Subpart H	Registration of Food Facilities. Facilities that make, process, pack or hold food for U.S. consumption register with FDA and renew every two years.	FDA · 21 CFR	14	Applies
21 CFR Part 1, Subpart J	Establishment, Maintenance, and Availability of Records. Keep records of the immediate previous source and the immediate subsequent recipient of food.	FDA · 21 CFR	13	Applies
21 CFR Part 1, Subpart D	Electronic Import Entries. Lists the data FDA needs in each electronic customs entry of an FDA-regulated article.	FDA · 21 CFR	12	Applies
21 CFR Part 1, Subpart I	Prior Notice of Imported Food. Imported food needs prior notice to FDA: at least 2 hours before arrival by road, 4 by rail or air, 8 by water.	FDA · 21 CFR	10	Applies
21 CFR Part 7, Subpart C	Enforcement Policy. FDA's recall policy: recalls are voluntary actions, classified by health hazard, with a recall strategy.	FDA · 21 CFR	10	Check
21 CFR Part 11	Electronic Records; Electronic Signatures. Electronic records and signatures that meet FDA record rules must be trustworthy, reliable and equivalent to paper.	FDA · 21 CFR	10	Applies
21 CFR Part 1, Subpart E	Imports and Exports. FDA import sampling, hearings and relabeling of refused goods, and the records kept for certain exports.	FDA · 21 CFR	9	Check
21 CFR Part 190	Dietary Supplements. A new dietary ingredient needs notification to FDA at least 75 days before marketing, unless the food-supply exception applies.	FDA · 21 CFR	1	Check
19 CFR Part 141	Entry of Merchandise. Entry of merchandise: liability for duties, who may enter, invoices, duty deposits and release.	Trade: CBP, OFAC, FWS	69	Applies
19 CFR Part 113	CBP Bonds. Customs bonds that secure payment of duties and compliance with import rules.	Trade: CBP, OFAC, FWS	53	Applies
19 CFR Part 142	Entry Process. The entry process: entry documents, entry summary, immediate delivery and line release.	Trade: CBP, OFAC, FWS	40	Applies
19 CFR Part 134	Country of Origin Marking. Country-of-origin marking of imported articles or their containers (§ 134.11).	Trade: CBP, OFAC, FWS	33	Applies
19 CFR Part 177	Administrative Rulings. Binding advance rulings from CBP, for example on tariff classification.	Trade: CBP, OFAC, FWS	25	Check
19 CFR Part 152	Classification and Appraisement of Merchandise. Tariff classification and customs valuation of imported goods.	Trade: CBP, OFAC, FWS	21	Applies
19 CFR Part 12 (selected subject groups)	Special Classes of Merchandise. CBP rules for FDA-regulated goods (§ 12.1), plants, goods made with forced labor, and goods under sanctions.	Trade: CBP, OFAC, FWS	16	Applies
19 CFR Part 149	Importer Security Filing. Importer Security Filing for ocean cargo; core data due 24 hours before loading at the foreign port.	Trade: CBP, OFAC, FWS	6	Check
7 CFR Part 319	Foreign Quarantine Notices. Conditions for importing plants and plant products that can carry pests; they depend on the commodity and origin.	USDA · 7 CFR	128	Check
7 CFR Part 330	Federal Plant Pest Regulations; General; Plant Pests, Biological Control Organisms, and Associated Articles; Garbage. Restrictions on moving plant pests, biological control organisms and associated articles, and on garbage.	USDA · 7 CFR	24	Check
7 CFR Part 357	Control of Illegally Taken Plants. Lacey Act plant declaration (§ 357.3): required for tariff codes on APHIS's phase-in schedule; "plant" excludes common cultivars and common food crops (§ 357.2). CFR atlas	USDA · 7 CFR	4	Check
40 CFR Part 180	Tolerances and Exemptions for Pesticide Chemical Residues in Food. Tolerances and exemptions for pesticide residues in food; inert-ingredient exemptions are in §§ 180.910–180.960.	EPA · 40 CFR	755	Applies
16 CFR Part 1700	Poison Prevention Packaging. Child-resistant packaging, including supplements with 250 mg or more elemental iron per package (§ 1700.14(a)(13)).	FTC and CPSC · 16 CFR	8	Check
29 CFR 1910.1200	Hazard communication.. Hazard communication: hazard classification, labels, safety data sheets and worker training.	OSHA · 29 CFR	1	Applies
29 CFR 1910.132	General requirements.. Workplace hazard assessment and personal protective equipment.	OSHA · 29 CFR	1	Applies
29 CFR 1910.147	The control of hazardous energy (lockout/tagout).. Lockout/tagout of hazardous energy during servicing and maintenance of machines.	OSHA · 29 CFR	1	Check
Total	30 rule sets; 18 apply, the rest apply only in the circumstances they name		1534	1258 in rules that apply

Economics, conceptually

Landed cost, documentation cost and inventory risk decide whether a qualified ingredient can carry a sustainable margin

EUTECNIQ has no supply agreements or sales, so no prices are shown. The structure below is how each opportunity would be assessed.

Seven costs build the landed cost per kilogram; the net selling price must clear it with room for quality cost and marginSchematic, equal steps, no values

Equal steps by construction: the figure shows the order and basis of each cost, not its size. No prices, margins or volumes are implied.International Chamber of Commerce, Incoterms 2020 (CIF is reserved for maritime trade); 19 U.S.C. 1401a(a)(1) and (b)(4)(A): customs value is normally the transaction value, excluding international freight and insurance.

Text version: cost build-up, margin and inventory risks

Landed cost per kilogram

Cost build-up at the U.S. warehousesupplier price + freight and insurance not in that price + duty + brokerage and fees + receipt testing + warehousing + cost of carrying inventory

Trade term. The Incoterms rule in the contract (ICC, 2020 edition) allocates costs, risks and obligations between seller and buyer, so it sets what the supplier's price already includes. CIF is reserved for maritime trade.
Duty base. U.S. customs value is normally the transaction value: the price paid or payable, excluding international freight and insurance (19 U.S.C. 1401a). An ad valorem duty is a rate applied to that value.
Quality cost. Verification testing, audits, retained samples and documentation are real costs per kilogram, largest for small volumes.
Carrying cost. Capital tied up in stock, storage, insurance, and the write-off of lots that pass their retest date.

Trade statistics report import values on different bases; the trade data page explains CIF and FOB-type reporting.

Margin and inventory risk

Gross margin would be measured as net selling price minus landed cost and allocated quality cost, divided by net selling price. The price a buyer accepts depends on what the documentation saves it: its own supplier audits, verification testing, failed lots and delays.

Minimum orders and lead times. Harvest seasons and batch sizes can force purchases larger than near-term demand.
Retest dates. Unsold stock can expire; stability data set how long it may be held.
Price and currency. Crop yields, weather and exchange rates move supplier prices between contracts.
Regulatory events. An import alert, a failed lot or a change in a rule can strand inventory.
Concentration. One supplier per ingredient means one failure stops supply; a second source needs its own qualification and comparability data.

Mitigations would include customer forecasts tied to purchase commitments, safety stock set from lead-time variability, price-adjustment clauses, and representative or co-development models while demand is unproven.

International Chamber of Commerce, Incoterms 2020 (iccwbo.org); 19 U.S.C. 1401a(a)(1) and (b)(4)(A) (Cornell LII).

Explanation, details and sources

The price a buyer accepts depends on what the documentation saves it: its own audits, verification testing, failed lots and delays. Inventory risk comes from harvest-driven minimum orders and lead times, retest dates, crop and currency price moves, regulatory events such as an import alert, and single-supplier concentration.

Mitigations would include forecasts tied to purchase commitments, safety stock set from lead-time variability, price-adjustment clauses, and representative or co-development models while demand is unproven.

Beyond the United States

A U.S. dossier does not open other markets, and each target market would be assessed on its own rules

Four other markets, four different first steps before a botanical ingredient can be soldLegal texts

Regulation (EU) 2015/2283, Arts. 3(2)(a), 6(2); Directive 2002/46/EC and COM(2008) 824; SOR/2003-196, ss. 4(1), 27(1); Consumer Affairs Agency of Japan, Foods with Function Claims. Details on international market access.

Explanation, details and sources

The proposed distribution focus is the United States. Other markets have their own authorization routes: for example, the EU novel food authorization, national rules for botanicals in EU food supplements, and Canada's natural health product licence. Traditional use elsewhere does not by itself authorize sale in the EU. See international market access.

How it would be built

The business would start with low-capital models and add inventory only after documentation and demand are proven

Each horizon would start when the previous one has produced evidence, not on a calendar date.

Capital need rises only as each horizon proves documentation and demandProposed sequence, illustrative timing

EUTECNIQ proposal. Capital need per model as in the commercial-model figure above (qualitative management judgment).

Text version of the three horizons

Horizon 1 · about months 0–12

Qualify and represent

Supplier qualification and gap assessments as paid projects
Verification testing through qualified external laboratories
Representative agreements where documentation is already sound

Proposed

Horizon 2 · about months 12–24

Distribute and co-develop

First exclusive distribution where demand supports minimums
Co-development of better-characterized grades and safety dossiers
Notification programs where an ingredient needs one

Proposed

Horizon 3 · about months 24–48

Own specifications

Private-label ingredients made to EUTECNIQ specifications
Master distribution for categories with many small buyers
Delivery-form ingredients where data support a benefit

Proposed

Discuss a supplier or ingredient program

Start with non-confidential information about the ingredient and your goals. A mutual NDA comes before any dossier, process detail or audit report is exchanged.

Supplier inquiry Buyer or development inquiry

Primary sources for this page (accessed October 22, 2026)

eCFR, 21 CFR Part 1, Subparts H (food facility registration), I (prior notice) and L (FSVP, including § 1.511), up to date as of 10/20/2026. ecfr.gov/current/title-21/…/part-1
FSVP final rule, 80 FR 74226 (November 27, 2015).
eCFR, 21 CFR 111.70, 111.75 and 111.1. ecfr.gov/current/title-21/…/part-111
eCFR, 21 CFR 117.405. ecfr.gov/current/title-21/…/part-117
eCFR, 19 CFR 142.3 and 142.12. ecfr.gov/current/title-19/…/part-142
21 U.S.C. 381(a). law.cornell.edu/uscode/text/21/381
19 U.S.C. 1401a. law.cornell.edu/uscode/text/19/1401a
U.S. FDA, Import Alerts (content current as of 03/03/2025). fda.gov/industry/actions-enforcement/import-alerts
21 CFR 190.6 and 21 U.S.C. 350b; 21 CFR 170.30; proposed rule, Substances Generally Recognized as Safe, 91 FR 51834 (August 11, 2026).
International Chamber of Commerce, Incoterms 2020. iccwbo.org/…/incoterms-2020
CITES Secretariat, How CITES works. cites.org/eng/disc/how.php